Skip to content

Safety and Efficacy Study of the QuickFlex Micro Model 1258T Left Heart Pacing Lead

QuickFlex Micro Model 1258T Left Heart Pacing Lead

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00763698
Enrollment
86
Registered
2008-10-01
Start date
2008-10-31
Completion date
2010-05-31
Last updated
2019-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Left heart pacing lead, Cardiac resynchronization therapy (CRT), Heart failure, ICD

Brief summary

This is a prospective, multi-center non-randomized clinical study to evaluate the safety and efficacy of the QuickFlex Micro Model 1258T left ventricular lead in a heart failure patient population. The study will be conducted at a maximum of 20 investigational centers located in the United States and a total of 68 patients will be enrolled.

Detailed description

The investigational left heart lead, QuickFlex Model 1258T, will be implanted with a legally marketed St. Jude Medical cardiac resynchronization therapy implantable cardioverter defibrillator (CRT-D) device. Patients will be followed at Pre-Discharge, 1-Month, 3-Month,and then every 6 months until the end of the study.

Interventions

DEVICEQuickFlex Micro Model 1258T Left Heart Lead

Implantation of QuickFlex Micro 1258T left heart lead in combination with a CRT-D system.

Sponsors

Abbott Medical Devices
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Approved indication for CRT-D system

Exclusion criteria

* Previous cerebrovascular accident (CVA) or transient ischemic attack (TIA) within 3 months of enrollment * Previous left ventricular (LV) lead implant * Have had a heart attack,unstable angina or cardiac revascularization (percutaneous transluminal coronary angioplasty (PTCA),coronary artery bypass grafting (CABG), Stent) within 40 days prior to enrollment

Design outcomes

Primary

MeasureTime frameDescription
Freedom From Left Ventricular Lead-related Complications3 monthsA Kaplan-Meier survival analysis was carried out for left ventricular lead related complications through 3 months. Percentage of patients who remained free from complications at 3 months was reported.
Percentage of Successful Left Ventricular Lead Implants3 monthsLeft ventricular lead implant success rate was calculated as the total number of patients who had a successful implant of the left ventricular QuickFlex Micro Model 1258T lead divided by the total number of patients who had an attempted implant. A successful implant was defined as the placement of the left ventricular lead in the coronary sinus for the purposes of pacing of the left ventricle with connection to the pulse generator.
Left Ventricular Bipolar Pacing Capture Threshold (Volts)3 monthsThe mean left ventricular capture threshold (amount of energy needed to pace the heart) is reported. An overall mean capture threshold of \< 3 volts is required to meet this endpoint.

Countries

United States

Participant flow

Recruitment details

The study was conducted at 18 investigational centers located in the United States (US). The first patient was enrolled on October 30, 2008 and follow up was completed on May 31, 2009.

Pre-assignment details

All patients were included in the study analysis with the exception of patients who underwent unsuccessful implantation of the 1258T lead system. These patients were followed for a period of 30 days and then were withdrawn from the study.

Participants by arm

ArmCount
QuickFlex Micro 1258T Left Heart Lead
All patients received a QuickFlex Micro 1258T left heart lead and were evaluated for freedom from left ventricular lead complications at 3 months. Left ventricular lead related complications is defined as any adverse event related to the left ventricular lead that requires an invasive intervention.
86
Total86

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDeath4
Overall StudyUnsuccessful Implant5
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicQuickFlex Micro 1258T Left Heart Lead
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
65 Participants
Age, Categorical
Between 18 and 65 years
21 Participants
Age, Continuous71.0 years
STANDARD_DEVIATION 11.3
Region of Enrollment
United States
86 participants
Sex: Female, Male
Female
29 Participants
Sex: Female, Male
Male
57 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
20 / 86
serious
Total, serious adverse events
4 / 86

Outcome results

Primary

Freedom From Left Ventricular Lead-related Complications

A Kaplan-Meier survival analysis was carried out for left ventricular lead related complications through 3 months. Percentage of patients who remained free from complications at 3 months was reported.

Time frame: 3 months

Population: Analysis was conducted on the 81 patients with a successful left ventricular lead implant.

ArmMeasureValue (NUMBER)
QuickFlex Micro 1258T Left Heart LeadFreedom From Left Ventricular Lead-related Complications100 percent of participants
Comparison: The objective performance criteria established for freedom from left ventricular lead related complications at 3 months was greater than 80%. At least 80% of the patients were required to be free from left venticular lead related complications at 3 months.Kaplan-Meier Survival Analysis
Primary

Left Ventricular Bipolar Pacing Capture Threshold (Volts)

The mean left ventricular capture threshold (amount of energy needed to pace the heart) is reported. An overall mean capture threshold of \< 3 volts is required to meet this endpoint.

Time frame: 3 months

Population: This effectiveness endpoint was carried out on the first 16 patients who had a LV lead bipolar pacing capture threshold measurement at 3 months at 0.5 ms pulse width. This patient cohort is referred to as the Primary Pacing Capture Threshold Patient Cohort.

ArmMeasureValue (MEAN)Dispersion
QuickFlex Micro 1258T Left Heart LeadLeft Ventricular Bipolar Pacing Capture Threshold (Volts)1.1 voltsStandard Deviation 0.3
Primary

Percentage of Successful Left Ventricular Lead Implants

Left ventricular lead implant success rate was calculated as the total number of patients who had a successful implant of the left ventricular QuickFlex Micro Model 1258T lead divided by the total number of patients who had an attempted implant. A successful implant was defined as the placement of the left ventricular lead in the coronary sinus for the purposes of pacing of the left ventricle with connection to the pulse generator.

Time frame: 3 months

Population: All patients with an implant or attempted implant were included in the analysis.

ArmMeasureValue (NUMBER)
QuickFlex Micro 1258T Left Heart LeadPercentage of Successful Left Ventricular Lead Implants94 percentage of participants
Wilson score interval method

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026